Log in

NYSE:FMSFresenius Medical Care AG & Co. Stock Price, Forecast & News

$42.20
+0.64 (+1.54 %)
(As of 05/29/2020 04:00 PM ET)
Add
Compare
Today's Range
$41.60
Now: $42.20
$42.25
50-Day Range
$34.26
MA: $38.09
$41.56
52-Week Range
$29.17
Now: $42.20
$42.24
Volume238,560 shs
Average Volume220,150 shs
Market Capitalization$25.18 billion
P/E Ratio18.92
Dividend Yield1.08%
Beta1.32
Fresenius Medical Care AG & Co. KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in Germany, the United States, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and water treatment systems for the treatment of ESRD; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, hospitalist, emergency, intensivist, medical cost management, ambulatory surgery center, health plan, urgent care, physician nephrology and cardiology, and ambulant treatment services. The company sells its products to clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of December 31, 2018, it operated 3,928 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
Read More
Fresenius Medical Care AG & Co. logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.4Community Rank: 1.9Dividend Strength: 3.3Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.77 out of 5 stars


Industry, Sector and Symbol

Industry Miscellaneous health & allied services, not elsewhere classified
Sub-IndustryN/A
SectorMedical
CUSIPN/A
Phone49-6172-608-2522

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$19.58 billion
Cash Flow$5.65 per share
Book Value$24.54 per share

Profitability

Net Income$1.34 billion

Miscellaneous

Employees120,659
Market Cap$25.18 billion
Next Earnings Date8/4/2020 (Estimated)
OptionableOptionable

Receive FMS News and Ratings via Email

Sign-up to receive the latest news and ratings for FMS and its competitors with MarketBeat's FREE daily newsletter.

Fresenius Medical Care AG & Co. (NYSE:FMS) Frequently Asked Questions

How has Fresenius Medical Care AG & Co.'s stock been impacted by COVID-19 (Coronavirus)?

Fresenius Medical Care AG & Co.'s stock was trading at $35.43 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, FMS stock has increased by 19.1% and is now trading at $42.20. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Fresenius Medical Care AG & Co.?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Fresenius Medical Care AG & Co. in the last year. There are currently 4 hold ratings, 8 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Fresenius Medical Care AG & Co..

When is Fresenius Medical Care AG & Co.'s next earnings date?

Fresenius Medical Care AG & Co. is scheduled to release its next quarterly earnings announcement on Tuesday, August 4th 2020. View our earnings forecast for Fresenius Medical Care AG & Co..

How were Fresenius Medical Care AG & Co.'s earnings last quarter?

Fresenius Medical Care AG & Co. (NYSE:FMS) announced its earnings results on Monday, August, 1st. The company reported $0.48 earnings per share for the quarter, missing the Zacks' consensus estimate of $0.49 by $0.01. The business had revenue of $4.42 billion for the quarter, compared to analysts' expectations of $4.54 billion. Fresenius Medical Care AG & Co. had a return on equity of 10.06% and a net margin of 6.80%. View Fresenius Medical Care AG & Co.'s earnings history.

What price target have analysts set for FMS?

13 brokerages have issued twelve-month price targets for Fresenius Medical Care AG & Co.'s shares. Their forecasts range from $40.23 to $48.00. On average, they anticipate Fresenius Medical Care AG & Co.'s share price to reach $44.15 in the next twelve months. This suggests a possible upside of 4.6% from the stock's current price. View analysts' price targets for Fresenius Medical Care AG & Co..

Has Fresenius Medical Care AG & Co. been receiving favorable news coverage?

Media coverage about FMS stock has been trending extremely negative this week, according to InfoTrie Sentiment. The research firm rates the sentiment of press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Fresenius Medical Care AG & Co. earned a news impact score of -4.0 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the next several days. View the latest news aboutFresenius Medical Care AG & Co..

Who are some of Fresenius Medical Care AG & Co.'s key competitors?

What other stocks do shareholders of Fresenius Medical Care AG & Co. own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Fresenius Medical Care AG & Co. investors own include Energy Transfer LP Unit (ET), Petra Diamonds (PDL), AT&T (T), Pfizer (PFE), AbbVie (ABBV), Abbott Laboratories (ABT), Chevron (CVX), Gilead Sciences (GILD), Netflix (NFLX) and Ford Motor (F).

Who are Fresenius Medical Care AG & Co.'s key executives?

Fresenius Medical Care AG & Co.'s management team includes the following people:
  • Mr. Robert Maurice Powell Jr., Chairman of the Mgmt Board & CEO of Fresenius Medical Care Mgmt AG (Age 64)
  • Mr. Michael Brosnan, CFO & Member of the Mgmt Board at Fresenius Medical Care Mgmt AG (Age 64)
  • Mr. Kent Wanzek, CEO of Global Mfg & Quality & Member of Mgmt Board - Fresenius Medical Care Mgmt AG (Age 60)
  • Dr. Olaf Schermeier, CEO of Global R&D and Member of the Mgmt Board - Fresenius Medical Care Mgmt AG (Age 47)
  • Mr. Harry de Wit, CEO of APAC & Member of Mgmt Board - Fresenius Medical Care Mgmt AG (Age 57)

What is Fresenius Medical Care AG & Co.'s stock symbol?

Fresenius Medical Care AG & Co. trades on the New York Stock Exchange (NYSE) under the ticker symbol "FMS."

Who are Fresenius Medical Care AG & Co.'s major shareholders?

Fresenius Medical Care AG & Co.'s stock is owned by a variety of institutional and retail investors. Top institutional investors include Morgan Stanley (0.24%), Morgan Stanley (0.24%), Parametric Portfolio Associates LLC (0.06%), Clearbridge Investments LLC (0.05%), NWQ Investment Management Company LLC (0.05%) and Aperio Group LLC (0.03%).

Which major investors are selling Fresenius Medical Care AG & Co. stock?

FMS stock was sold by a variety of institutional investors in the last quarter, including Morgan Stanley, Morgan Stanley, NWQ Investment Management Company LLC, Deutsche Bank AG, SG Americas Securities LLC, US Bancorp DE, Envestnet Asset Management Inc., and Franklin Resources Inc..

Which major investors are buying Fresenius Medical Care AG & Co. stock?

FMS stock was acquired by a variety of institutional investors in the last quarter, including Clearbridge Investments LLC, Parametric Portfolio Associates LLC, UBS Group AG, RMB Capital Management LLC, Raymond James & Associates, Balyasny Asset Management LLC, JPMorgan Chase & Co., and Aperio Group LLC.

How do I buy shares of Fresenius Medical Care AG & Co.?

Shares of FMS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Fresenius Medical Care AG & Co.'s stock price today?

One share of FMS stock can currently be purchased for approximately $42.20.

How big of a company is Fresenius Medical Care AG & Co.?

Fresenius Medical Care AG & Co. has a market capitalization of $25.18 billion and generates $19.58 billion in revenue each year. The company earns $1.34 billion in net income (profit) each year or $2.53 on an earnings per share basis. Fresenius Medical Care AG & Co. employs 120,659 workers across the globe.

What is Fresenius Medical Care AG & Co.'s official website?

The official website for Fresenius Medical Care AG & Co. is www.freseniusmedicalcare.com.

How can I contact Fresenius Medical Care AG & Co.?

Fresenius Medical Care AG & Co.'s mailing address is ELSE-KROENER STRASSE 1, BAD HOMBURG 2M, 61352. The company can be reached via phone at 49-6172-608-2522 or via email at [email protected]

This page was last updated on 5/31/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.